Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",18931,130,0.88 [0.59-1.31],0.5187729431983914
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19752,150,1.22 [0.94-1.60],0.136057792410447
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",19543,1129,0.90 [0.79-1.03],0.1212360092436948
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Candidiasis,19759,290,0.93 [0.72-1.20],0.5812767368848872
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,19175,2796,0.91 [0.84-0.99],0.0302726642473808
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),19165,2817,1.04 [0.96-1.12],0.3308921475669559
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,19583,852,0.90 [0.77-1.05],0.1620550371913283
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,19704,66,1.03 [0.63-1.68],0.9083564376699178
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,17947,880,0.93 [0.80-1.08],0.3480082036579667
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,17308,963,0.92 [0.80-1.06],0.2745243949603244
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,17124,192,0.85 [0.60-1.19],0.3336821075348778
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,13883,1822,1.03 [0.93-1.13],0.5850236470162762
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,17069,326,1.03 [0.82-1.29],0.8032518410749179
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,19752,1021,0.94 [0.82-1.07],0.3585203135181283
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Mycoses,19831,362,0.93 [0.74-1.17],0.5342154297430106
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,19124,710,1.03 [0.89-1.19],0.7147341390557427
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,19770,969,0.93 [0.81-1.07],0.3379210137609224
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,18883,152,1.20 [0.91-1.57],0.1960901028308467
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,19864,40,0.40 [0.15-1.06],0.0656796391522204
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,19646,845,0.94 [0.81-1.09],0.3794692214742341
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19689,51,1.36 [0.90-2.04],0.1421416138005233
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,19808,97,1.10 [0.75-1.60],0.6249196451609713
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",19794,83,0.99 [0.63-1.55],0.9546089734001708
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,18803,389,0.82 [0.64-1.05],0.1103224065894205
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,18646,232,0.80 [0.58-1.11],0.1788901175587094
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,18800,69,0.64 [0.33-1.22],0.1763582918160749
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,19846,56,0.74 [0.38-1.46],0.3873277396611104
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,19816,124,1.14 [0.83-1.57],0.4064160428136932
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Viral warts,19738,46,1.32 [0.86-2.02],0.2057761024522725
CASQ2,Calsequestrin-2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],19737,45,1.11 [0.64-1.92],0.7208474718335438
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign lipomatous neoplasm,19605,289,1.18 [0.97-1.44],0.0990269465070709
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,19806,41,1.21 [0.72-2.03],0.4698648613257689
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,19774,49,1.38 [0.94-2.03],0.1044280933073161
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,19825,107,1.12 [0.78-1.59],0.5426581519370393
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",19553,1363,0.99 [0.88-1.10],0.8072680775776884
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm of meninges,19863,25,1.35 [0.77-2.39],0.2973470925411418
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,19814,56,1.07 [0.64-1.78],0.7914474390596618
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,19852,65,0.74 [0.40-1.39],0.3477669012208623
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,19842,380,0.92 [0.74-1.16],0.4880559512230447
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Caecum,19844,287,1.06 [0.84-1.33],0.623534587596649
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",19755,62,1.40 [1.01-1.95],0.044484589186547
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Descending colon,19840,241,0.85 [0.63-1.14],0.2805333823976138
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Rectum,19803,347,0.72 [0.55-0.94],0.0178919841735485
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,19761,617,1.14 [0.99-1.32],0.0751931584134419
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,19830,460,0.83 [0.67-1.03],0.0973349867051654
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",15485,61,0.34 [0.15-0.76],0.0081823946543139
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",15482,58,1.06 [0.66-1.73],0.8004037968121576
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",19837,79,1.17 [0.79-1.73],0.427666942225295
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Haemangioma, any site",19837,76,1.19 [0.80-1.75],0.3864498972016349
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Lung cancer and mesothelioma,13247,297,1.05 [0.84-1.32],0.6571080002228151
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Lymphoid leukaemia,15480,56,0.35 [0.15-0.80],0.0133753265226824
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",15585,161,0.75 [0.51-1.11],0.1482772137259301
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",15662,238,1.00 [0.77-1.29],0.9960455634237
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",15500,76,0.69 [0.38-1.26],0.2267909696549455
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",15530,106,1.04 [0.72-1.51],0.845487746269108
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",15545,121,1.10 [0.79-1.54],0.5707430050447597
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",15494,70,1.09 [0.71-1.69],0.6951733597954552
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",16567,1143,0.82 [0.71-0.94],0.0056774316794785
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",15551,127,1.07 [0.77-1.49],0.6894385426172254
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",15513,89,1.12 [0.76-1.63],0.5761579728156303
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,15526,102,1.11 [0.78-1.57],0.5708235485170641
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Melanocytic naevi,19766,145,0.89 [0.61-1.29],0.5374797682916124
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Melanocytic naevi of trunk,19838,85,0.76 [0.44-1.30],0.308888950097766
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Melanoma in situ,15452,62,0.64 [0.33-1.26],0.1994094700391038
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",15509,85,0.80 [0.48-1.35],0.4078077824521454
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",15563,139,0.67 [0.43-1.04],0.0761925334543981
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",15616,192,0.93 [0.68-1.27],0.6472910642875457
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",15510,86,0.93 [0.58-1.48],0.7564563147986261
CASQ2,Calsequestrin-2,Chapter II Neoplasms,Other benign neoplasms of skin,19753,123,1.39 [1.09-1.78],0.008862044827881
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",16411,987,0.99 [0.87-1.13],0.889552562705436
CASQ2,Calsequestrin-2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",16472,1048,1.00 [0.88-1.13],0.9904006133361606
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19636,243,1.07 [0.84-1.36],0.5970355394730783
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,18462,63,0.90 [0.52-1.56],0.6972568292342547
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,19450,57,1.04 [0.62-1.75],0.8739411096801926
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,19434,2247,1.05 [0.97-1.14],0.2353359355134208
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,18854,51,0.56 [0.26-1.24],0.1561266458300152
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,19517,42,1.33 [0.85-2.07],0.2079998160152263
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,19590,1191,1.09 [0.98-1.21],0.1200467734563417
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,19588,1189,1.09 [0.98-1.22],0.113846024191298
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,18476,77,0.95 [0.58-1.54],0.8316004903725642
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,19679,876,1.01 [0.88-1.16],0.8669931920899169
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,19564,89,0.94 [0.60-1.49],0.8042209943652138
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,19453,60,1.09 [0.67-1.78],0.7179197168099891
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,19448,55,0.54 [0.25-1.17],0.1200115919493055
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,19728,253,1.05 [0.82-1.34],0.6968259922091454
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,19783,38,1.18 [0.68-2.05],0.5682053816266186
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",19682,207,1.07 [0.82-1.39],0.629873678907414
CASQ2,Calsequestrin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,18862,59,0.69 [0.35-1.35],0.2808120241916741
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,14719,301,1.18 [0.96-1.45],0.1137219941330836
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,18154,136,0.87 [0.59-1.28],0.4939430886719118
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,18175,157,1.12 [0.86-1.47],0.3986187652286864
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,14466,48,0.85 [0.43-1.67],0.6280848012225597
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,18748,53,1.26 [0.83-1.92],0.27676695144856
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,18129,177,0.95 [0.68-1.31],0.7504711353728732
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",19484,471,0.98 [0.81-1.19],0.8633486078972072
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,19205,192,0.76 [0.53-1.08],0.1250609658076983
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,19127,114,0.86 [0.56-1.33],0.5087958811450028
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,19614,919,0.98 [0.86-1.13],0.8257564167280068
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,17026,887,0.98 [0.86-1.13],0.8064350129560225
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",14479,61,1.09 [0.65-1.80],0.7488782690596483
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",19171,36,0.83 [0.37-1.85],0.6498605288167179
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,14635,217,0.87 [0.63-1.19],0.3693845043028851
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,14479,61,1.19 [0.76-1.88],0.4427027834042706
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,17619,3201,1.00 [0.93-1.08],0.9722157886622392
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,14571,153,1.13 [0.84-1.53],0.4098224936305289
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,14876,458,0.98 [0.81-1.20],0.8666601075984703
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,19818,218,0.85 [0.62-1.16],0.3080197811908526
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,19666,66,1.05 [0.66-1.69],0.8358244192484613
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,14543,125,1.05 [0.73-1.50],0.8043079823578622
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",14471,53,0.61 [0.28-1.29],0.1952520634627871
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,19713,578,1.06 [0.90-1.24],0.4919006065721626
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,14654,236,1.02 [0.78-1.32],0.895054838261875
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,14696,278,0.89 [0.67-1.17],0.4037284307148895
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15014,596,1.13 [0.97-1.32],0.117571426557767
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,14531,113,1.15 [0.81-1.63],0.4408063958997568
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,19661,61,1.16 [0.75-1.81],0.4961987012848379
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,14895,477,1.10 [0.93-1.31],0.28117828942177
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,14743,325,0.88 [0.68-1.14],0.3301586071549231
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,17997,45,1.11 [0.64-1.92],0.7144662732984561
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18717,4299,1.01 [0.95-1.07],0.8423722491736495
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,19146,11,0.99 [0.28-3.52],0.9934564619558136
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,19155,20,1.71 [1.08-2.71],0.022188700785607
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,19728,1451,0.96 [0.87-1.07],0.4503671827594089
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",19724,1446,0.96 [0.87-1.07],0.4859726591015496
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,19146,11,1.31 [0.57-2.99],0.5242280819855407
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,19639,674,1.04 [0.89-1.21],0.6422657989008982
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",15729,1311,1.07 [0.96-1.19],0.2371365837640507
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,19856,195,1.05 [0.79-1.39],0.7572486201898927
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,19095,82,0.79 [0.46-1.35],0.3835865856766877
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,19027,62,1.05 [0.64-1.72],0.8549447647802867
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,19039,74,0.94 [0.57-1.56],0.8077328588203715
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",14472,54,1.16 [0.71-1.90],0.5607900090655722
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17535,137,0.94 [0.66-1.36],0.7584126461479836
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2105,101,1.29 [0.90-1.84],0.1615603222846152
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2242,265,1.07 [0.81-1.40],0.6469558998054856
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,17476,78,1.37 [0.99-1.90],0.0581430756156386
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2060,56,1.29 [0.77-2.17],0.337448020912379
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,19234,1836,0.94 [0.85-1.04],0.2515008424312283
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,19279,266,1.06 [0.84-1.34],0.6082264485790467
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,18147,195,1.41 [1.16-1.70],0.0004026589556648
CASQ2,Calsequestrin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,15037,619,0.98 [0.82-1.16],0.779522434701793
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19755,201,0.93 [0.68-1.26],0.6215761327017357
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),18868,231,1.04 [0.80-1.34],0.7871846941834142
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Angina pectoris,17475,1223,1.05 [0.94-1.17],0.417688294642933
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,18963,326,1.02 [0.81-1.27],0.8785967318355509
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,18702,65,1.35 [0.94-1.93],0.1068997129537338
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",18825,188,0.95 [0.69-1.30],0.7491613056919397
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11632,1869,1.06 [0.97-1.15],0.1802503592612825
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,AV-block,16066,498,0.99 [0.83-1.19],0.9395678345213498
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",19805,429,0.88 [0.71-1.10],0.2603739028305978
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Cardiac arrest,9968,205,1.34 [1.09-1.65],0.0055646728553333
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,15733,165,0.74 [0.50-1.10],0.1351026407570276
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",15656,88,0.96 [0.60-1.51],0.849485158834187
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,19865,48,1.00 [0.56-1.78],0.9979323924594048
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Conduction disorders,16679,1111,1.09 [0.97-1.22],0.1392833092111043
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,18401,2168,1.02 [0.94-1.11],0.6561391757156156
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,16814,6487,0.99 [0.94-1.04],0.762131829692938
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,18846,220,1.02 [0.78-1.33],0.8999471987953428
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Endocarditis,15638,70,0.81 [0.45-1.44],0.4685821787933792
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",19601,1081,0.99 [0.88-1.12],0.9201043647763448
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Hypertension,17803,5646,1.00 [0.95-1.06],0.9443448806907764
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",17809,5652,1.00 [0.95-1.06],0.9851363913262946
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",19675,97,1.05 [0.71-1.55],0.8125502269265819
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12321,164,1.11 [0.81-1.53],0.5144276067200573
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12249,92,1.06 [0.68-1.64],0.8086560728589625
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Hypotension,19745,971,1.02 [0.89-1.16],0.7960870599685753
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,18998,95,0.82 [0.50-1.33],0.4204158203968677
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",18511,2259,1.05 [0.97-1.14],0.2068954150880442
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",19528,539,0.97 [0.81-1.16],0.7014358543120258
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,15910,342,1.09 [0.88-1.34],0.4436287684606816
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,19278,885,1.09 [0.96-1.23],0.2066356887240764
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",17016,764,1.10 [0.96-1.25],0.1842378727351911
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",19728,187,1.00 [0.74-1.35],0.9921463158360968
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",19821,316,1.18 [0.98-1.43],0.0868474877625417
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Oesophageal varices,18682,56,0.46 [0.21-1.02],0.05753629814596
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other aneurysm,18708,71,0.93 [0.56-1.57],0.7930100863677472
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other arrhythmias,15971,403,0.86 [0.68-1.08],0.1975292811891608
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,18744,107,1.15 [0.82-1.62],0.4213082246121805
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,18862,225,1.12 [0.88-1.43],0.3630467273935547
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,15718,150,0.98 [0.69-1.39],0.9203145152885543
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other disorders of veins,18698,72,1.05 [0.66-1.66],0.8343286742809295
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,18667,41,1.04 [0.56-1.91],0.9111883308861288
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,18570,75,1.08 [0.69-1.68],0.7482306344284678
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,18712,86,1.21 [0.85-1.71],0.2933456714273661
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,16586,1018,0.87 [0.75-1.00],0.0571193743546522
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,18827,53,0.66 [0.32-1.37],0.2665493013585273
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,19093,456,1.11 [0.93-1.32],0.2431620171949409
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,19329,307,0.96 [0.75-1.22],0.7382652284492806
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",19035,540,0.99 [0.83-1.19],0.9478684489078724
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,10068,305,1.04 [0.82-1.31],0.7515483256407816
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,19012,415,1.15 [0.97-1.37],0.1155205171631968
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),18911,285,0.98 [0.76-1.25],0.8556693242919402
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,19428,406,0.95 [0.77-1.18],0.6472732088285451
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,19812,576,0.98 [0.83-1.17],0.8428039929137112
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,15960,392,1.17 [0.98-1.40],0.0747194300798825
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,19328,306,0.97 [0.76-1.23],0.7923160937441381
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,18674,179,0.84 [0.60-1.20],0.3417400479432352
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",19515,612,0.96 [0.81-1.13],0.6140798904121042
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",19504,637,0.97 [0.82-1.14],0.7244315576845072
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,18983,39,1.07 [0.59-1.95],0.8188582281052329
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,18732,96,0.97 [0.63-1.49],0.8876303922936145
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,19183,194,1.01 [0.76-1.35],0.943051748586029
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18653,260,0.99 [0.76-1.28],0.9245030215332248
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Varicose veins,18939,313,0.94 [0.73-1.19],0.5926571383525088
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,18653,61,0.87 [0.48-1.57],0.6375131537219696
CASQ2,Calsequestrin-2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,19655,633,0.96 [0.81-1.13],0.6156664236503713
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",19692,405,1.07 [0.89-1.29],0.4916176817913591
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",17120,815,0.97 [0.84-1.13],0.704923112470645
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Any mental disorder,19284,2979,0.97 [0.90-1.05],0.4565380213177138
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19639,474,1.04 [0.87-1.24],0.6789591414012885
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",17259,954,0.99 [0.87-1.13],0.892870971201352
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",16369,64,0.62 [0.31-1.22],0.1630096106682156
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Smoking dependency,19312,1287,1.01 [0.90-1.12],0.911555780848472
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",17856,1551,1.02 [0.93-1.12],0.6887856641786034
CASQ2,Calsequestrin-2,Chapter V Mental and behavioural disorders,Vascular dementia,19486,118,0.97 [0.66-1.43],0.8931643582934703
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Alzheimer disease,19864,242,0.82 [0.60-1.11],0.1884914288869216
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",13287,46,0.74 [0.34-1.58],0.4321856439383482
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Bell's palsy,18725,67,1.27 [0.87-1.85],0.2136013918010643
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,18948,290,0.94 [0.73-1.21],0.6540208282635975
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Cerebral cysts,19534,195,1.14 [0.89-1.47],0.2964764249851129
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,19790,275,0.77 [0.57-1.04],0.0841389194970806
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,19463,55,0.70 [0.35-1.40],0.3151631250647185
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,19849,66,0.86 [0.49-1.51],0.5924772547613899
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",19415,76,1.07 [0.69-1.66],0.7596856803289312
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Epilepsy,18539,228,0.77 [0.56-1.07],0.1238272115476065
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,19428,1117,0.95 [0.83-1.08],0.3997245027955252
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,19832,392,1.05 [0.86-1.27],0.6571387717975596
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,19406,1760,1.02 [0.93-1.13],0.6232258843990439
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Generalized epilepsy,19551,48,0.65 [0.30-1.41],0.2771045150780751
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Hemiplegia,19729,214,0.77 [0.55-1.08],0.1324204221419958
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Hydrocephalus,19387,48,1.12 [0.66-1.90],0.6821123688636848
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,19848,49,0.63 [0.29-1.38],0.2485152318141503
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,18678,20,1.00 [0.41-2.45],0.992669397981096
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,18737,79,1.28 [0.90-1.81],0.1633390956169386
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Memory loss,19353,102,0.62 [0.36-1.06],0.0788810483790396
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Migraine,18472,161,0.83 [0.57-1.20],0.3200573823139735
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",19844,146,0.66 [0.43-1.03],0.0657121484730743
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Motor neuron disease,13390,137,1.01 [0.72-1.43],0.9385340070620616
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,19765,57,1.06 [0.64-1.74],0.83085269754372
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",19465,807,1.05 [0.92-1.20],0.478529017337258
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Neurological diseases,18761,2927,0.99 [0.92-1.07],0.8285284889513673
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,19589,181,1.03 [0.77-1.38],0.8290511817163502
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",18962,304,0.97 [0.76-1.23],0.7835991160126796
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",19790,287,1.14 [0.92-1.40],0.236002186063305
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,15687,504,0.94 [0.78-1.14],0.5291684054436314
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,19402,63,0.67 [0.34-1.30],0.2374505447666647
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,19462,123,0.76 [0.49-1.19],0.2372201661200556
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,19549,109,0.97 [0.65-1.44],0.8695022313662527
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,18742,84,1.18 [0.82-1.71],0.3723338336003043
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other headache syndromes,18344,33,1.20 [0.68-2.12],0.5260904287565321
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other neurological diseases,19767,428,1.02 [0.84-1.24],0.8454857671624877
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Other sleep disorders,18889,578,1.00 [0.85-1.18],0.9649937102624128
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Parkinson's disease,19843,264,1.09 [0.87-1.37],0.4425470003545525
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,19361,22,1.45 [0.85-2.48],0.1730552864330924
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Restless leg syndrome,19863,35,0.85 [0.39-1.85],0.6741899050928027
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Sleep apnoea,19622,524,1.02 [0.86-1.21],0.8182776841617417
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,19550,47,1.08 [0.61-1.91],0.7857892986213151
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,19847,157,1.11 [0.82-1.48],0.5046101313549591
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,18686,28,0.97 [0.44-2.16],0.9500778583848764
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,19864,245,0.81 [0.60-1.09],0.1679097613105982
CASQ2,Calsequestrin-2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),19459,114,1.02 [0.70-1.48],0.9304089292754746
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,19421,67,0.87 [0.49-1.53],0.6224523108738609
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,19578,240,0.69 [0.49-0.97],0.0333174568724618
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19714,246,0.99 [0.76-1.29],0.9310369818440576
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,19132,34,0.43 [0.15-1.22],0.1143419153379271
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,19150,52,0.79 [0.40-1.56],0.4981273782878441
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",19790,35,1.18 [0.65-2.14],0.5792136923749345
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,19676,102,0.58 [0.33-1.02],0.057788231122506
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2060,56,1.26 [0.74-2.13],0.3960435931061181
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2511,106,1.28 [0.89-1.83],0.1772096681022871
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,19434,80,0.57 [0.30-1.06],0.0761370525385076
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,19673,825,0.95 [0.82-1.10],0.4994440006564826
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",19601,503,0.90 [0.74-1.10],0.3166845661598123
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,19213,115,0.85 [0.55-1.31],0.4520585742137907
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",19803,465,0.80 [0.64-1.00],0.0489031969277433
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,19862,54,0.52 [0.23-1.14],0.1001365668858135
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,19751,413,0.71 [0.55-0.91],0.0081840402072603
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",19834,260,0.74 [0.54-1.01],0.0568183453058397
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,19790,124,0.88 [0.58-1.32],0.5256885366242255
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,19162,64,1.30 [0.90-1.87],0.1595692997892538
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,19169,71,0.94 [0.56-1.56],0.8094148167715651
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,19132,34,1.32 [0.79-2.21],0.2971542374768336
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,19787,571,0.97 [0.81-1.16],0.732018090185812
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,19380,164,0.94 [0.67-1.32],0.7049938023858575
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,19360,22,1.05 [0.46-2.39],0.9021854497654218
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,19654,80,0.78 [0.45-1.35],0.3695894203417744
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,19758,184,0.69 [0.47-1.02],0.0630433707972078
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,19485,147,0.79 [0.53-1.18],0.2555736790419035
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,19733,67,0.95 [0.56-1.61],0.845583369801957
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,19586,370,0.88 [0.69-1.11],0.2794261195597057
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,19449,95,1.02 [0.68-1.54],0.9261332907327776
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,18753,1476,0.99 [0.89-1.10],0.8194561355300513
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,19734,160,0.66 [0.43-1.01],0.0537279908371633
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,19849,117,0.84 [0.54-1.30],0.4303750314332558
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,19443,345,1.02 [0.82-1.26],0.8732522859731697
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,19631,57,0.58 [0.28-1.23],0.1562334677636967
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,19852,44,0.62 [0.27-1.43],0.2632410822136153
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,19159,61,0.83 [0.45-1.51],0.5384320719154475
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,19222,124,1.00 [0.69-1.44],0.9958434598615536
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,18952,104,0.88 [0.56-1.37],0.5709949579052293
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,19375,37,1.27 [0.76-2.11],0.364982162254566
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",18898,50,1.19 [0.75-1.88],0.4546902470216769
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,19259,43,1.45 [0.97-2.15],0.0677147396285735
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",19384,168,0.87 [0.61-1.24],0.4461502920989993
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,19186,88,1.01 [0.65-1.56],0.9662324550994668
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,18949,101,1.16 [0.82-1.64],0.3962753998853032
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,18925,77,0.73 [0.41-1.30],0.288001846301691
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,18466,1189,0.85 [0.74-0.98],0.0216404441150637
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,19144,46,0.90 [0.46-1.74],0.7491224246677766
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,19662,308,0.82 [0.62-1.07],0.1427255245699275
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,19410,56,1.05 [0.62-1.78],0.8562324532700543
CASQ2,Calsequestrin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),19476,122,1.06 [0.75-1.50],0.7506184686952699
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,19710,50,1.11 [0.65-1.89],0.7065594092707141
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,19828,104,1.14 [0.80-1.62],0.4672638126069188
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,19751,95,0.73 [0.44-1.24],0.2447192624028444
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,19704,44,1.20 [0.72-1.98],0.4873087521335788
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,19706,46,1.24 [0.77-1.98],0.3785019488440339
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,19780,764,1.01 [0.88-1.17],0.8594612258576471
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,19587,571,0.99 [0.84-1.18],0.9291209977114
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,19123,107,1.15 [0.81-1.63],0.4236729786690324
CASQ2,Calsequestrin-2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,19082,66,1.32 [0.92-1.89],0.1298658630801907
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Acute pharyngitis,19686,46,0.75 [0.36-1.58],0.448928894001749
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,19794,154,0.98 [0.70-1.38],0.9200301090160544
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,19690,50,0.40 [0.17-0.95],0.0373802027287482
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,All influenza,18019,83,0.98 [0.62-1.54],0.925628473492403
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),18016,80,1.02 [0.65-1.59],0.9478503032246092
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),13037,87,1.38 [1.04-1.82],0.0255019826707384
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Allergic rhinitis,19777,228,1.10 [0.85-1.41],0.4723582823365543
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",13861,1197,1.07 [0.96-1.20],0.2203150378992959
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",14126,1176,1.07 [0.96-1.20],0.2457308250397863
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),19538,119,1.09 [0.77-1.54],0.6314567964913556
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",18008,72,1.10 [0.71-1.72],0.6722090768156221
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Bronchiectasis,17253,238,1.10 [0.87-1.40],0.4241023096721389
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",17051,36,1.21 [0.71-2.06],0.4906598845089259
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,19144,2129,1.09 [1.00-1.18],0.0418280404926526
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",18648,68,1.12 [0.72-1.75],0.6107553557152687
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Chronic sinusitis,18711,131,1.06 [0.76-1.48],0.7416511077627316
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",19680,1080,1.09 [0.97-1.22],0.1659057525503393
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Deviated nasal septum,18705,125,1.09 [0.78-1.52],0.6042605515589121
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,18173,4350,1.07 [1.01-1.13],0.0204532470737452
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",18913,333,1.09 [0.89-1.34],0.3973722649584634
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Early onset COPD,18865,265,1.23 [1.02-1.49],0.0346124439884393
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Emphysema,17313,298,0.99 [0.78-1.25],0.9352420594533966
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,19072,295,1.07 [0.87-1.33],0.5153287899260126
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,19655,1719,1.06 [0.97-1.17],0.1812888765323952
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Interstitial lung disease,19092,315,1.07 [0.87-1.32],0.5228149476377311
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Later onset COPD,18949,815,1.01 [0.88-1.16],0.882504985137133
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,19848,324,1.19 [0.99-1.44],0.062991169313818
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Nasal polyp,18708,128,1.02 [0.72-1.45],0.9019479612465282
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,19632,796,1.01 [0.88-1.17],0.8607565099597329
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other diseases of pleura,19630,1818,1.05 [0.96-1.15],0.3169741923082259
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19316,736,1.05 [0.91-1.21],0.5401883092547258
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other pleural conditions,17861,49,1.41 [0.96-2.06],0.079279052245528
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,19770,387,1.09 [0.90-1.32],0.3778286084944852
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,19759,1154,1.06 [0.94-1.18],0.3391404599157963
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Pleural effusion,18726,914,1.01 [0.88-1.15],0.9299453694198806
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Pleural plaque,18034,222,0.94 [0.70-1.25],0.6649699491219633
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",19443,1507,1.10 [1.00-1.20],0.0591466503295287
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,19762,238,1.27 [1.04-1.56],0.018967616358346
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Pneumothorax,17931,119,1.08 [0.76-1.52],0.6770065230357496
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Pollen allergy,19849,195,1.07 [0.81-1.41],0.6161268645153644
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Pulmonary oedema,19441,58,1.34 [0.92-1.95],0.1297907677603284
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,12995,45,1.20 [0.72-2.00],0.4765688953703663
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,19617,781,1.02 [0.88-1.17],0.8145168003518533
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,18809,229,1.09 [0.85-1.40],0.5134967909594708
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Viral pneumonia,18163,227,1.01 [0.77-1.33],0.955439321304897
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",19558,193,0.84 [0.59-1.18],0.316170928581111
CASQ2,Calsequestrin-2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,8714,90,1.04 [0.70-1.56],0.8320281590535884
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,13909,73,1.15 [0.77-1.71],0.5030669437555325
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Acute appendicitis,19754,122,1.19 [0.88-1.61],0.2539628117315035
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Acute gastritis,15056,70,0.90 [0.53-1.53],0.7034082515319908
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Acute pancreatitis,18735,172,0.84 [0.59-1.19],0.3251661328447043
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Acute peritonitis,19567,77,0.69 [0.38-1.26],0.2278391642678645
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,19103,91,1.35 [1.01-1.81],0.0420246621847129
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Barrett oesophagus,15413,427,1.03 [0.86-1.25],0.7287604573570771
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",18665,102,0.98 [0.65-1.47],0.919320685943638
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",19519,102,0.99 [0.66-1.48],0.9599512273889694
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Cholecystitis,18742,179,0.91 [0.66-1.27],0.579631259217896
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Cholelithiasis,19224,661,0.91 [0.77-1.08],0.2736714785547578
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Chronic gastritis,15198,212,0.99 [0.74-1.31],0.9227263139993817
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,18612,49,0.76 [0.37-1.53],0.44011410928524
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",19693,115,1.05 [0.73-1.50],0.8071886843277735
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Coeliac disease,18489,72,1.21 [0.81-1.78],0.3505037293129363
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Collagenous colitis,18661,41,0.87 [0.43-1.77],0.692660976971863
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,19717,185,0.92 [0.67-1.28],0.6336849103712995
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Constipation,19733,1270,1.02 [0.91-1.14],0.7836958018200311
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Crohn disease,18697,77,0.93 [0.57-1.53],0.78364425399599
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19570,56,0.83 [0.45-1.56],0.5705535141729067
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,18685,65,1.03 [0.63-1.67],0.9162587326520192
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Dental caries,19327,184,1.24 [0.98-1.57],0.0754429464367816
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,16855,1596,0.96 [0.86-1.07],0.4564417734789426
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of appendix,19780,148,1.18 [0.90-1.56],0.2316874013742608
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of liver,19748,736,1.02 [0.88-1.18],0.7869159544433044
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",18191,3205,0.98 [0.91-1.05],0.532693821219664
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19558,415,1.16 [0.97-1.37],0.0985483202456478
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,19825,335,1.01 [0.81-1.26],0.9005445887066669
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,19232,89,1.38 [1.04-1.84],0.0277528090990898
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,19121,51,0.74 [0.37-1.50],0.409307629834946
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,19601,1184,1.03 [0.91-1.15],0.6490736601753211
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diseases of tongue,19132,95,1.24 [0.89-1.72],0.1959442534966866
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",19565,1002,0.94 [0.82-1.08],0.3919195552493227
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,16392,2556,0.98 [0.90-1.06],0.619371396276313
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Duodenal ulcer,15199,213,0.97 [0.73-1.29],0.8284141103586109
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",19765,165,0.89 [0.63-1.26],0.516085244523648
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,19804,35,0.71 [0.30-1.71],0.449941641828915
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,19146,134,1.00 [0.70-1.42],0.9938424129919649
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,13985,149,0.96 [0.68-1.35],0.8121158035870548
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Functional dyspepsia,15334,348,0.99 [0.80-1.23],0.9363153868834356
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastric ulcer,15295,309,1.01 [0.80-1.26],0.9626138480159292
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,16752,1766,0.95 [0.86-1.05],0.3018230331450038
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,15476,490,0.98 [0.82-1.18],0.8428571303419342
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,15186,6621,0.96 [0.91-1.01],0.1005760667640466
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,GI-bleeding,19395,978,1.02 [0.89-1.16],0.8014923376937918
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,19185,42,1.39 [0.91-2.13],0.1257915897723739
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,14604,998,0.99 [0.87-1.12],0.8280265891850975
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",19082,70,0.56 [0.28-1.09],0.0886968236392001
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Hernia,18165,2906,0.92 [0.85-1.00],0.0488541524975044
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Impacted teeth,19807,34,0.74 [0.31-1.76],0.4955102280210085
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Impaction of intestines,13870,34,1.26 [0.73-2.15],0.4063109864525341
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Inguinal hernia,16618,1359,0.96 [0.85-1.07],0.4255122121480141
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",15418,159,0.94 [0.67-1.31],0.7194432548770362
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,13912,76,1.22 [0.84-1.78],0.2906274233285582
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18501,84,1.11 [0.75-1.66],0.5946368147103673
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,14075,239,0.87 [0.65-1.17],0.3556271980567469
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,19827,314,1.03 [0.82-1.28],0.8186067621689871
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,19177,557,0.96 [0.80-1.15],0.6593065436205583
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,19355,735,1.01 [0.87-1.17],0.9219154053186972
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,15162,176,1.08 [0.82-1.43],0.5780027852123537
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Oesophagitis,15509,523,1.03 [0.87-1.22],0.7120441506488506
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,19816,90,0.90 [0.56-1.44],0.6487297632795368
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,15321,62,0.76 [0.41-1.43],0.3997081872132674
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,15043,1207,0.96 [0.85-1.08],0.4871889265267102
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,18779,216,0.97 [0.74-1.29],0.8588053910355351
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,18664,101,0.88 [0.56-1.37],0.5618465209413954
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of intestine,15407,1571,0.93 [0.83-1.04],0.1792486544942827
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of intestines,18346,4510,0.96 [0.90-1.02],0.2219250112531562
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,19102,148,0.97 [0.69-1.37],0.8611239876696067
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of liver,19599,587,1.04 [0.88-1.22],0.6623416932582271
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,15586,600,1.02 [0.87-1.20],0.7970447168661313
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,18678,115,1.07 [0.75-1.51],0.7251195743213747
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,19772,282,1.07 [0.85-1.34],0.572529760276275
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,15643,657,0.96 [0.82-1.13],0.6338142997511361
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,19404,987,1.02 [0.90-1.16],0.7158930238899744
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,19286,143,0.95 [0.67-1.36],0.788649128410442
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,15136,1300,1.01 [0.90-1.13],0.8518945430525355
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),16518,1532,0.98 [0.88-1.08],0.6456356339298239
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,19091,79,0.59 [0.31-1.10],0.0937941646226824
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,19260,640,0.97 [0.82-1.14],0.7058450342107052
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",14121,285,1.12 [0.90-1.39],0.3078372925544176
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,19795,43,0.88 [0.43-1.77],0.7126089876625721
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,14227,391,1.07 [0.88-1.30],0.4791513932372301
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18561,144,1.02 [0.73-1.43],0.8897702880823439
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,19851,34,0.86 [0.39-1.91],0.7199161605947455
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,19149,84,1.00 [0.64-1.57],0.9852854236675676
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Toxic colitis,18656,36,1.42 [0.93-2.16],0.1007579511781714
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,15237,251,0.93 [0.71-1.21],0.5817693620162924
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Ulcerative colitis,18746,126,1.15 [0.84-1.57],0.381082330093924
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18725,105,1.25 [0.92-1.68],0.1470813945482295
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Umbilical hernia,15553,294,0.72 [0.54-0.97],0.0316046188941989
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,13967,131,0.78 [0.51-1.20],0.2602842889045548
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Ventral hernia,15472,213,0.79 [0.57-1.10],0.1581506809382233
CASQ2,Calsequestrin-2,Chapter XI Diseases of the digestive system,Volvulus,13896,60,0.82 [0.44-1.52],0.525210097083572
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,19811,262,1.11 [0.89-1.38],0.3740814527007765
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,19609,60,0.91 [0.52-1.60],0.7406181132697942
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,18236,80,0.58 [0.31-1.08],0.0863869679173074
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,19249,625,0.94 [0.79-1.12],0.4763109991655254
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",18792,168,0.64 [0.42-0.97],0.0366578868271061
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,18518,362,1.08 [0.89-1.32],0.4170399406487215
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,19621,218,0.99 [0.75-1.31],0.9396340159215536
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,19785,382,1.09 [0.90-1.32],0.388860240970594
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,19440,37,1.09 [0.59-2.00],0.7923242434058927
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,18613,2597,0.96 [0.88-1.04],0.2755425730428644
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19481,335,0.86 [0.66-1.10],0.2240952704692436
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19384,238,0.64 [0.45-0.90],0.011623373798414
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,19469,845,0.96 [0.83-1.11],0.5813099042072651
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",19854,24,0.68 [0.23-2.01],0.4830613619192605
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,18179,23,0.78 [0.28-2.17],0.6318412978916789
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,19196,50,1.00 [0.56-1.77],0.9970953433343066
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,19617,214,1.00 [0.76-1.32],0.9883896708270548
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,18556,400,0.80 [0.63-1.01],0.0623617692020934
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,18223,67,0.74 [0.40-1.36],0.3338430404740587
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,19811,66,1.30 [0.90-1.88],0.1547689156655888
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,18786,162,1.35 [1.08-1.69],0.0085350672360581
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19723,174,1.01 [0.75-1.37],0.9391465117635184
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,19457,54,1.59 [1.19-2.12],0.0019126423078719
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,18208,52,0.82 [0.43-1.58],0.5563457196416222
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,19481,1325,0.97 [0.87-1.09],0.6180847778325783
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",18593,437,0.79 [0.63-1.00],0.0512462305826885
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,18226,70,0.75 [0.42-1.36],0.3459108929148121
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,19790,241,0.99 [0.76-1.29],0.9371582897938806
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,19449,46,0.95 [0.51-1.79],0.8748862362649086
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19760,211,1.00 [0.76-1.33],0.9798901617682064
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,19826,277,1.09 [0.88-1.36],0.4291076717925602
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,18232,76,0.59 [0.31-1.11],0.103897763661093
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,18375,219,1.01 [0.77-1.32],0.95778128333304
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,19821,272,1.09 [0.87-1.36],0.4715558381324032
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",18361,205,1.15 [0.90-1.47],0.2681038371231818
CASQ2,Calsequestrin-2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,19843,98,1.03 [0.69-1.53],0.8893861669346319
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,17121,71,0.98 [0.60-1.60],0.9351009346048582
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,18116,3935,0.99 [0.92-1.05],0.6772075859741489
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,16955,2774,1.00 [0.93-1.08],0.9866474395715524
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,17115,65,1.27 [0.87-1.85],0.2132273778967695
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,17464,120,1.17 [0.85-1.60],0.3419383505944844
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,17461,117,1.03 [0.71-1.48],0.8880223064062895
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,19687,53,0.97 [0.55-1.73],0.92540477284661
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",17410,66,1.08 [0.67-1.74],0.7463480707064623
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,14903,722,1.01 [0.87-1.17],0.9196695959844322
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19760,125,1.14 [0.84-1.55],0.3945333994057564
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,17558,214,0.80 [0.57-1.11],0.1847255654328497
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,16902,5171,0.96 [0.91-1.02],0.1626230445405992
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,19008,80,1.12 [0.75-1.68],0.5764018931562813
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,17185,135,0.85 [0.57-1.27],0.430616308624722
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,17426,376,1.00 [0.81-1.23],0.9713396199676244
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,19172,1828,1.04 [0.95-1.14],0.4142019571569489
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,17363,313,0.92 [0.72-1.18],0.5015835494045844
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,17097,47,0.84 [0.43-1.67],0.6234197856818883
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,17135,85,1.06 [0.70-1.61],0.7797337630999361
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,19596,26,0.78 [0.30-2.02],0.6052340569929144
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,15368,1187,0.94 [0.83-1.06],0.3353763525598805
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14973,792,0.98 [0.85-1.14],0.7993720136214304
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",19750,779,0.98 [0.85-1.13],0.782525315219623
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14217,36,1.24 [0.73-2.11],0.4186935482210672
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14250,69,0.91 [0.54-1.54],0.7232116357572668
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,17272,222,1.14 [0.91-1.44],0.2578243665900605
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14697,516,0.96 [0.80-1.15],0.6714150848324768
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,17374,30,1.29 [0.74-2.24],0.3667648692107826
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,17774,430,1.07 [0.89-1.28],0.4965772159553006
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,17557,213,0.72 [0.51-1.02],0.0675091355910844
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14663,482,0.97 [0.80-1.17],0.7281348092202125
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,17105,55,0.74 [0.37-1.47],0.3896804676923399
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",17091,41,0.74 [0.34-1.63],0.4550096616371478
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,19001,73,1.02 [0.64-1.65],0.9216143479733804
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,19622,694,0.96 [0.82-1.13],0.6116891965760354
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,19245,317,0.97 [0.77-1.22],0.7828515592203426
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",19798,250,0.98 [0.75-1.27],0.8804803178306305
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,15723,1542,0.99 [0.89-1.09],0.7882307776896538
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,14222,41,1.05 [0.58-1.90],0.8660528520003803
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,17113,63,1.18 [0.77-1.81],0.4375444565951665
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,14230,49,1.13 [0.68-1.89],0.6292798705265747
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14217,36,0.98 [0.49-1.93],0.9445696125068448
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,19083,155,0.92 [0.65-1.31],0.6391751385835536
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,19057,129,0.93 [0.64-1.37],0.715447763921937
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,19835,69,0.91 [0.54-1.55],0.7327270650895605
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",18587,1243,1.02 [0.91-1.14],0.7573434956914105
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,17104,54,1.30 [0.87-1.95],0.1935652314675165
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14216,35,0.65 [0.27-1.59],0.3494116966068913
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,17853,509,0.89 [0.73-1.09],0.2619981514183983
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,15585,1404,0.96 [0.86-1.08],0.5046945556179041
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,19612,42,0.93 [0.48-1.82],0.8409052328335036
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,19851,55,0.86 [0.46-1.59],0.6248068290891234
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,17121,71,0.88 [0.52-1.50],0.6347638184660688
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",17860,810,1.04 [0.91-1.20],0.5395363788003873
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,17126,76,0.83 [0.49-1.43],0.5089411555980288
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,15178,997,0.98 [0.86-1.12],0.7944648286249905
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,19000,72,0.88 [0.52-1.50],0.6390948351223875
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,17087,37,1.14 [0.65-2.00],0.643698677227735
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,17440,96,0.97 [0.63-1.50],0.8950855338493695
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,17460,410,1.11 [0.92-1.32],0.2755481529043327
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19733,163,0.69 [0.46-1.03],0.0715753875618982
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,17743,399,1.11 [0.93-1.34],0.2445255301976378
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,19806,247,0.97 [0.74-1.27],0.8231208153606333
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,19851,32,1.43 [0.91-2.24],0.124502875423989
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,17176,126,1.01 [0.70-1.44],0.9704319207107724
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,16310,468,0.87 [0.71-1.07],0.1941391847703121
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,17445,395,1.03 [0.84-1.26],0.7819963981850231
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],17334,284,0.91 [0.70-1.18],0.4681674384247446
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",14206,25,0.55 [0.18-1.70],0.2953883594394973
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16054,1873,0.99 [0.90-1.09],0.8333393003473235
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14548,367,1.00 [0.81-1.23],0.98034217387402
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,19705,135,0.74 [0.48-1.13],0.1651513125751271
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",19801,35,0.93 [0.45-1.92],0.8502298160005727
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",18230,35,0.58 [0.23-1.50],0.264028106284957
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,14238,57,0.88 [0.49-1.59],0.676903516519582
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,17417,73,0.99 [0.61-1.61],0.973601793517106
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14437,256,1.06 [0.83-1.35],0.6352365113676688
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,17291,241,1.06 [0.83-1.36],0.6304727359361593
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,17520,176,0.98 [0.71-1.34],0.8988182475581978
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,17410,66,0.86 [0.49-1.52],0.6077966704390207
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,15807,26,0.65 [0.23-1.87],0.4262711738479015
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",19852,33,1.55 [1.06-2.28],0.0249478267284189
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,17494,444,1.09 [0.91-1.29],0.355022107100618
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],19587,17,1.08 [0.43-2.70],0.8653239949082071
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,18955,1905,1.02 [0.93-1.12],0.6973314407809255
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",17138,88,0.76 [0.45-1.29],0.3155627847337042
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,17748,404,0.89 [0.71-1.12],0.3264206763822982
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,18971,170,0.99 [0.72-1.35],0.9441980884873452
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,17459,115,0.71 [0.44-1.16],0.1693300626575952
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,18421,1077,1.04 [0.93-1.18],0.4768598124464924
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,18005,661,1.12 [0.97-1.29],0.1276315083489266
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],17082,32,0.82 [0.35-1.89],0.6410142487012622
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,19605,35,0.91 [0.43-1.92],0.8054611105736156
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,17158,108,0.74 [0.45-1.20],0.2200962828914763
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,17066,16,0.50 [0.12-2.20],0.3618780215952966
CASQ2,Calsequestrin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),14231,50,0.63 [0.29-1.36],0.2384982762067684
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,19133,1482,0.97 [0.87-1.08],0.6130040864067492
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19463,329,0.95 [0.75-1.20],0.6827392555754701
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,19257,123,1.23 [0.93-1.64],0.1514381445286317
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,18765,1114,1.02 [0.90-1.15],0.7441799308234405
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,19670,45,1.02 [0.57-1.83],0.9455839493661812
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,19666,284,0.93 [0.72-1.20],0.5792609157572213
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Cystitis,17523,167,0.88 [0.62-1.25],0.4600661353618317
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Dialysis,17714,63,0.98 [0.58-1.67],0.9534337433368232
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,18818,2749,0.96 [0.88-1.04],0.309158741321143
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,17951,4605,0.98 [0.92-1.04],0.4840263176047769
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,19695,70,1.30 [0.91-1.86],0.1542691903190332
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Hydrocele,16244,175,0.75 [0.52-1.10],0.1441493148569823
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,17724,288,0.85 [0.65-1.11],0.2374273963220941
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,18218,2149,0.95 [0.87-1.04],0.2966265279445801
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16266,197,0.79 [0.56-1.12],0.1907890390108246
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,17416,60,0.82 [0.45-1.51],0.5310737009579058
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,16168,99,1.05 [0.71-1.55],0.8062719180134029
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",19858,52,1.15 [0.71-1.87],0.5747030929209611
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",19858,41,0.63 [0.27-1.47],0.2873410473496876
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,19178,1822,0.91 [0.82-1.01],0.0860067728690666
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,18155,799,0.85 [0.73-1.01],0.0605913580390188
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,19811,429,1.00 [0.83-1.22],0.9619812580517848
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16327,258,0.78 [0.58-1.06],0.1097820084798393
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16306,237,1.02 [0.79-1.32],0.8729620611344
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,16257,188,1.06 [0.80-1.40],0.6996460772602686
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,19854,41,1.39 [0.91-2.11],0.1251552665563775
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,18571,1215,0.90 [0.79-1.02],0.1033271961685031
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,17758,322,0.86 [0.67-1.11],0.2500271530604812
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,19526,144,1.14 [0.85-1.53],0.3898621539238589
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,19678,53,1.15 [0.72-1.86],0.5557643276951222
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16289,220,0.99 [0.75-1.30],0.950978660875612
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19658,2222,0.98 [0.90-1.07],0.6384192858626525
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",17488,52,0.68 [0.33-1.40],0.2915906425116359
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,17761,110,1.24 [0.92-1.66],0.1594277657560542
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19197,63,0.63 [0.32-1.24],0.1792195542292321
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,17604,248,0.99 [0.77-1.29],0.9677167439982176
CASQ2,Calsequestrin-2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19568,434,0.99 [0.81-1.20],0.8952462567053691
